Candel Therapeutics Shares up 19.3% Premarket on Positive Mid-Stage Trial Data for Lung Cancer Treatment
由於肺癌治療的中期試驗數據良好,Candel Therapeutics股價盤前上漲19.3%
Candel Therapeutics Shares up 19.3% Premarket on Positive Mid-Stage Trial Data for Lung Cancer Treatment
由於肺癌治療的中期試驗數據良好,Candel Therapeutics股價盤前上漲19.3%
譯文內容由第三人軟體翻譯。